Agenus Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include LogicBio Therapeutics and AstraZeneca.
 LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Lexington, US HQ Louisville, US | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more |
Employees | Employees 188 | Employees 4178% increase | Employees 94,300 |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 176.3 m | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) | Revenue (est.) $58.7b (FY, 2025) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($40m) (FY, 2021) | Net income $10.2b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 49m | Total funding raised $ 1b |
For sources of this data, please see the company profile
View Company Profiles
LogicBio Therapeutics
HQ
Lexington, US
Employees
41
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company